That is necessary, due to the fact that the method a protein in the body folds determines if a pharmaceutical will be able to bind to that protein and be efficient. To put it simply, we need to understand how these proteins fold if we want a drug to work. Historically, this has actually been a trial-and-error process (jeff brown stock predictions). Now, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it a lot easier to produce drugs that do what they're developed to do. This was an advancement practically nobody discovered. But it's going to have profound ramifications for treating illness. I anticipate that Alpha, Fold will be 98% precise by the end of 2021.
And, of course, there will be plenty of investment chances in this space, too. Shifting subjects It's going to be a great year for bitcoin. I'm bullish on it in 2021 (second wave). That said, I still think bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be surprised if it drew back possibly substantially before going higher - future report. I've been covering bitcoin for a very long time now. One of the very first research study reports I ever released was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial suggestion, I titled my report "What's the Big Offer With Bitcoin?" That reveals you where the discussion was at the time. We were mainly informing readers. However that's not the big question anymore. Now we're seeing institutional money lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche enterprise. Mass, Mutual is a trusted 170-year-old organization. So think about that. In five years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
And that's a big reason I'm bullish on it this year. jeff brown genome sequencing stock. Regards, Jeff Brown, Editor, The Bleeding Edge I have a reward forecast 2020 was a record year for IPOs. 552 U.S. business went public the most in more than 20 years. These companies raised a total of $172 billion. That's an all-time high beating the previous annual record by 43%. I predict 2021 will be another record year in IPOs. There are numerous great personal business on the brink of striking the public markets And I've been working on a brand-new way for you to invest even before these companies go public.
This chance has been constructing over the last couple of years. I can't wait to tell you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to learn all the details. Go right here to reserve your spot free of charge.
Emma Walsh here, handling editor of the Journal. Routine Diary readers know that tech isn't our typical beat (legacy report prediction). And when it comes to tech investing, we leave it to the professionals. Luckily, we have several such specialists in our Rolodex. Our coworker Jeff Brown will recognize to our longtime readers. He is among the most accomplished tech investing professionals we know (exponential tech investor). In truth, he had numerous triple-digit returns in his Brownstone Research study portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to take an appearance at the huge picture and predict what's just around the corner.
That consists of things like 5G networks, biotech, artificial intelligence, and a lot more. These trends are experiencing exponential growth and creating incredible chances for investors. I wish to make certain all our readers are gotten ready for what's next. And with that in mind, let me draw the photo of what I see being available in the next 12 months Our brand-new 5G (fifth-generation) cordless networks are a subject I've been covering for years now. jeff brown top biotech stock 2021. But despite what many readers may think, this is a trend that's just beginning. Despite the fact that the COVID-19 pandemic interfered with supply chains last year, a remarkable 250 million 5G-enabled gadgets were still offered.
And all of this eventually resulted in Apple postponing the release of the 5G-enabled i, Phone 12 by 2 months (united states). Losing 2 months of production and sales really affects the number of 5G gadgets are sold in the fiscal year. When you consider all of that, offering 250 million systems is impressive. More notably, the hold-ups triggered by the pandemic created a lots of pent-up need. Which need is now going to be pressed into 2021. In fact, I anticipate that more than 500 million 5G gadgets will be shipped in 2021 - jeff brown investment prediction. And that's not my only 5G forecast When I have actually talked about 5G in the past, I've explained its 3 various phases.
In Stage 2, 5G devices go on sale. 5G phones and other products start to reach consumers. And in Phase 3, 5G services begin to be provided (jeff brown stock market prediction). That's when we begin to see applications operating on 5G networks. Think about things like massive multiplayer video games over a mobile phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G prediction for 2021 is that we will begin Phase 3 by this summer. This starts something of a virtuous cycle: Many people don't truly care about the innovation. However they will care if there are amazing applications that can only be accessed with a 5G phone.
That leads to more 5G apps being developed. In truth, 5G is going to open a suite of incredible applications: self-driving vehicles, the Internet of Things, robotic surgery, and more. All of these innovations need 5G. The investment chances going forward will be enormous. Stepping away from 5G, the next crucial innovation I anticipate in 2021 is CRISPR genetic editing. CRISPR means "clustered routinely interspaced short palindromic repeat." It's a mouthful. But it's one of the most exciting advancements in biotechnology. At a high level, CRISPR is a technology that can edit our genetic makeup as if it were software application.
The program can crash or not work correctly. CRISPR utilizes a similar idea however with our genetic code. "Typos" in our genome can cause disease. CRISPR can fix these "typos." For several years, CRISPR was mainly a specific niche innovation that wasn't well understood. And during that time, there were truly just three companies running in this area. But things are altering. CRISPR is no longer just theoretical. We're seeing actual results. We're treating diseases and seeing that this technology simply works. And as an outcome, a "second crop" of early-stage CRISPR business is going public and delivering extraordinary returns. This whole market is successfully a greenfield opportunity.
There's room for many companies to exist in this area. jeff brown predictions for 2021. And there will be more. That's my prediction for CRISPR in 2021. I anticipate that two or 3 more hereditary editing companies will hold their IPOs. Sticking with biotechnology, we are seeing amazing things happening at the convergence of biotech and synthetic intelligence (AI). Google's AI subsidiary, Deep, Mind, just revealed at the end of 2020 that its newest Alpha, Fold software application can precisely forecast the folding of a protein based entirely on its amino acid sequence with 92. 4% precision. That is very important because the method a protein in the body folds identifies if a pharmaceutical will be able to bind to that protein and be reliable.
Historically, this has actually been a trial-and-error process. However now, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it a lot easier to develop drugs that do what they're designed to do. And here's my next forecast. I forecast that Alpha, Fold will be 98% precise by the end of 2021. And we will see not simply one however numerous drug treatments produced utilizing this innovation. This was among those advancements that almost no one observed. But it's going to have extensive ramifications for treating disease. And, obviously, there will be a lot of financial investment chances in this area, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That stated, I still think bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be surprised if it pulled back perhaps significantly prior to going greater. I've been covering bitcoin for a long time now. Among the first research reports I ever published was on bitcoin - legacy report prediction. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on investment for any person who followed my suggestion. However at the time of that preliminary recommendation, I titled my report, "What's the Big Deal With Bitcoin?" That reveals you where the conversation was at the time.
However nobody is asking that concern any longer. Now, we're seeing institutional money finally taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, niche enterprise. jeff brown 2020 predictions. Mass, Mutual is a 150-year-old organization. So think of that. In 5 years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a big reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more perk prediction In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown is worth about $27. 5 million and claims the information depends on date as of February 2021, however we might not independently verify this claim. Offered Jeff Brown's past, he likely has a significant net worth, however we can't hammer down an accurate figure at this moment. Brown is best known for his sage-like ability to choose winning innovation stocks. He spent more than 25 years investigating innovation companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience provides him an outstanding perspective on the market. He's always on the hunt for brand-new opportunities, and he shares much of his finest picks in the Future Report.
That's full marks, however it's not ridiculously reasoned. Brown has an excellent reputation as a stock-picker, and he successfully forecasted some of the biggest financial occasions of the previous 20 years. Although he doesn't appear to release his choices to the public, the service's success is a direct sign of Brown's stock-picking expertise. Nobody on Wall Street gets it best every time, but Jeff Brown's accurate predictions have actually earned him legions of dedicated fans. That states a lot about his capability. The Near Future Report is published by Brownstone Research, a popular monetary research study publisher. Brownstone Research provides numerous research study services with a wide range of specializations - future report.
The company is likewise associated with Bonner & Partners, another well-respected research publisher - artificial intelligence. On its site, Brownstone states its mission is to offer retail investors with professional-grade research: "For too long, the best investment research has actually not been offered to individual financiers. It has actually been typically booked for financial investment banks, hedge funds, private equity, and high-net-worth customers. brownstone research. The objective of Brownstone Research study is to make that kind of exclusive research study readily available to any financiers wanting to acquire an edge in the markets. The objective is basic to provide unique and rewarding financial investment research discovered nowhere else." -Brownstone Research study site excerpt from the Jeff Brown is the founder of Brownstone Research study, and he likewise acts as the company's Chief Financial investment Analyst.
With Brown guiding the ship, Brownstone Research study is a powerhouse publisher with lots to provide its clients. After decades of stable success at the helm of top-tier business like Tesla and Space, X, Elon Musk is a household name throughout most of America. If you understand even a little bit about the market, you understand that he has a track record as a King Midas of sorts. artificial intelligence. Everything he touches relies on gold! Jeff is well conscious of Elon Musk's executive prowess, so he constantly has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next huge task.
In reality, Brown thinks S.A.V. tech stock. could be "the greatest pattern of the 2020s, and he's not alone. Have a look at these quotes from other widely known S.A.V. bulls: Elon's next big act will be marrying 2 innovative innovations: artificial intelligence and electric cars and trucks. Musk hopes the combination will help him develop the first fully-autonomous, self-driving automobiles ever. It's absolutely nothing short of the automotive market's Holy Grail. As you understand, electric vehicles and self-driving car stocks have actually been substantial this year, but the Wall Street machine has approved hype without much tangible result. In spite of an extreme boost in competitors over the past few years, Brown still believes Musk has the best possibility of putting everything together.
tech might be the magic string that connects all of it together. S.A.V. stands for Shared Autonomous Lorry, and it could be the future of transport. Basically, this innovation would allow you to lease your car as a self-governing, self-driving taxi when you're not using it. You just get out of the cars and truck and press a button on an app that informs the vehicle to "join the fleet." Next thing you understand, you're relaxing on your couch while your cars and truck shuttles ride-sharers around town. Best of all, you get to keep a substantial portion of the profits. It sounds outrageous, but it could be closed than you think.